Composing on-program triggers and on-demand stimuli into biosensor drug carriers in drug delivery systems for programmable arthritis therapy

YY Lim, AMA Zaidi, A Miskon - Pharmaceuticals, 2022 - mdpi.com
Medication in arthritis therapies is complex because the inflammatory progression of
rheumatoid arthritis (RA) and osteoarthritis (OA) is intertwined and influenced by one …

Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy

S Thongchot, K Aksonnam… - International …, 2023 - spandidos-publications.com
The benefits of treating several types of cancers using immunotherapy have recently been
established. The overexpression of nucleolin (NCL) in a number of types of cancer provides …

[HTML][HTML] A top-down approach to uncover the hidden ligandome of low-density lipoprotein receptor-related protein 1 in cartilage

K Yamamoto, C Scavenius, MM Meschis… - Matrix Biology, 2022 - Elsevier
The low-density lipoprotein receptor-related protein 1 (LRP1) is a cell-surface receptor
ubiquitously expressed in various tissues. It plays tissue-specific roles by mediating …

A Unique G-Quadruplex Aptamer: A Novel Approach for Cancer Cell Recognition, Cell Membrane Visualization, and RSV Infection Detection

CD Xiao, MQ Zhong, Y Gao, ZL Yang, MH Jia… - International Journal of …, 2023 - mdpi.com
Surface staining has emerged as a rapid technique for applying external stains to trace
cellular identities in diverse populations. In this study, we developed a distinctive aptamer …

Development of hybrid aptamers-engineered PROTACs for degrading VEGF165 in both tumor-and vascular endothelial cells

Z Feng, D Xie, F Qiu, J Huang, Z Wang… - European Journal of …, 2025 - Elsevier
Tumors and angiogenesis are connected through a complex interplay. VEGF165, generated
from both tumor and vascular endothelial cells, serves as a mutual benefit for both cell types …

Limb expression 1‐like protein promotes epithelial–mesenchymal transition and epidermal growth factor receptor‐tyrosine kinase inhibitor resistance via nucleolin …

M Li, J Zhang, X Meng, B Liu, SM Xie, F Liu… - Cancer …, 2023 - Wiley Online Library
Limb expression 1‐like protein (LIX1L) might be an RNA‐binding protein involved in post‐
transcriptional regulation. However, little is known regarding the biological function and …

Uncovering the ligandome of low-density lipoprotein receptor-related protein 1 in cartilage: a top-down approach to identify therapeutic targets

K Yamamoto, C Scavenius, MM Meschis… - bioRxiv, 2022 - biorxiv.org
The low-density lipoprotein receptor-related protein 1 (LRP1) is a cell-surface receptor
ubiquitously expressed in adult tissues. It plays tissue-specific physiological roles by …

[HTML][HTML] 核仁素在结肠癌组织中的表达及临床意义

曲竑宇, 李泽群, 刘学超, 李毅, 牛兆建 - Advances in Clinical …, 2024 - hanspub.org
目的: 核仁素(Nucleolin, NCL) 已被证明在肿瘤中发挥重要作用, 但结肠癌中NCL
表达情况尚不明确. 本研究旨在探究NCL 在结肠癌中的表达情况与结肠癌临床病理特征以及 …

Evaluating the Role of RUNX2 in Cancer and Its Potential as a Therapeutic Target

R Pulica, K Cohen-Solal, A Lasfar - Handbook of Cancer and Immunology, 2022 - Springer
RUNX2, the transcription factor of the RUNX family, plays a critical role in homeostasis and a
variety of pathological conditions, including cancer. RUNX2 was first described as a master …